BTNL タンパク質による保存された γδ T 細胞選択は,ヒトの炎症性腸疾患の進行を制限する
Robin J Dart1,2,3, Iva Zlatareva1,2, Pierre Vantourout1,2
1Peter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.
Science (New York, N.Y.)
|September 14, 2023
まとめ
CD103+Vγ4+細胞を含むヒトの大腸のガンマデルタT細胞は,組織保護に不可欠です. 炎症性腸疾患と クローン病のリスクに関連しています
科学分野:
- 免疫学
- 胃腸内科
- 細胞生物学
背景:
- ネズミの内皮質のガンマデルタT細胞は,皮質のブチロフィリン型 (BTNL) ヘテロマーによって選択され,組織を保護する.
- 人間の免疫の保存メカニズムを理解することは 病気の洞察にとって極めて重要です
研究 の 目的:
- ヒトの大腸におけるBTNL依存型 γδ T細胞の保存を調査する.
- ヒトの大腸の γδ T 細胞区画と炎症性腸疾患 (IBD) の役割の特徴を明らかにする.
主な方法:
- T細胞受容体 (TCR) Vγ4およびCD103発現を含むヒト大腸のγδT細胞のフェノタイプ特性.
- 炎症性腸疾患 (IBD) の患者および健康な対照群における γδ T 細胞サブセットの分析
- クローン病 (CD) に関する生殖線BTNL3/BTNL8低形状の調査
主要な成果:
- Vγ4 と CD103 を共発するヒト大腸の γδ T 細胞サブセットが特定されました.
- このCD103+Vγ4+ γδ T細胞サブセットは,IBDでは減少し,制御不能であった.
- CD103+ γδ T細胞の回復はIBDの寛解と相関しており,BTNL3/ BTNL8の低形状はCDの浸透のリスク要因であった.
結論:
- BTNL依存の選択/組織内部の γδ T 細胞の維持は進化的に保たれています.
- この軸は,炎症性腸疾患における組織損傷を制限する役割を果たします.
- CD103+Vγ4+ γδ T細胞の調節不良はIBDとCDの病原性に関与しています.
さらに関連する動画
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
2.6K
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
47.6K
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
01:30Inflammatory Bowel Disease II: Crohn's Disease
285
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
168
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
168
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213